{ "items": [ "\n\n
\n \n 12 September 2019\n \n
\n\n \n\n \n\n \n \n \n \n OCH\n \n \n\n \n\n\n
\n \n\n \n \n \nMany congratulations to Dr Simona Valletta, a postdoctoral research in MRC MHU, who was awarded an Intermediate Research Fellowship from the Kay Kendall Leukaemia Fund.
\n \n\n\n \n 11 July 2019\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n General\n \n \n \n \n OCH\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers at the MRC MHU uncover the specific gene mutations that are required for the development of leukaemia in children with Down\u2019s syndrome.
\n \n\n\n \n 2 July 2019\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n General\n \n \n \n \n OCH\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 2 July 2019\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n General\n \n \n \n \n MRC WIMM\n \n \n \n \n OCH\n \n \n\n \n\n\n
\n \n\n \n \n \nMedical Sciences Division is delighted to welcome Dr Anjan Thakurta to Oxford, having now taken up his position of Visiting Professor of Cancer, Biology and Translational Science within the Radcliffe Department of Medicine.
\n \n\n\n \n 28 February 2019\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n General\n \n \n \n \n MRC MHU\n \n \n \n \n MRC WIMM\n \n \n \n \n OCH\n \n \n\n \n\n\n
\n \n\n \n \n \nPatients, carers, clinicians and researchers collaborate to decide key research questions for future research.
\n \n\n\n \n 12 February 2019\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n General\n \n \n \n \n OCH\n \n \n\n \n\n\n
\n \n\n \n \n \nAnalysing tumours cell by cell will help develop personalised cancer treatments.
\n \n\n\n \n 23 November 2018\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n General\n \n \n \n \n MRC WIMM\n \n \n \n \n OCH\n \n \n\n \n\n\n
\n \n\n \n \n \nDeutsche Bank employees across the UK raised this generous sum via their \u2018One Day\u2019 initiative, in collaboration with Cure Leukaemia
\n \n\n\n \n 28 August 2018\n \n
\n\n \n\n \n\n \n \n \n \n MRC MHU\n \n \n \n \n MRC WIMM\n \n \n \n \n NDCLS\n \n \n \n \n OCH\n \n \n\n \n\n\n
\n \n\n \n \n \nDr Anna Rose at the MRC Molecular Haematology Unit will study disease pathogenesis and prognosis in a subset of patients with Myelodysplastic Syndromes.
\n \n\n\n \n 7 August 2018\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n EDI\n \n \n \n \n General\n \n \n \n \n IMD\n \n \n \n \n MRC MHU\n \n \n \n \n MRC WIMM\n \n \n \n \n NDCLS\n \n \n \n \n OCDEM\n \n \n \n \n OCH\n \n \n\n \n\n\n
\n \n\n \n \n \nCongratulations to Professor Leanne Hodson (Professor of Metabolic Physiology), Professor Adam Mead (Professor of Haematology) Professor Gary Ford (Professor of Stroke Medicine) and Professor Damian Tyler (Professor of Physiological Metabolism) who were all awarded the title of full professor in the recent Recognition of Distinction.
\n \n\n\n \n 16 July 2018\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n MRC MHU\n \n \n \n \n MRC WIMM\n \n \n \n \n NDCLS\n \n \n \n \n OCH\n \n \n\n \n\n\n
\n \n\n \n \n \nThe study led by MRC WIMM researchers as part of an international team aims to understand what happens when patients stop responding to treatment.
\n \n\n\n \n 19 June 2018\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n MRC MHU\n \n \n \n \n MRC WIMM\n \n \n \n \n NDCLS\n \n \n \n \n OCH\n \n \n\n \n\n\n
\n \n\n \n \n \nThe recommendations result from research by Prof Irene Roberts and Prof Paresh Vyas, published today in the British Journal of Haematology.
\n \n\n\n \n 12 February 2018\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n MRC MHU\n \n \n \n \n MRC WIMM\n \n \n \n \n NDCLS\n \n \n \n \n OCH\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nCongratulations to Dr James Davies and Dr Lynn Quek, who have both been awarded MRC Clinician Scientist Fellowships.
\n \n\n\n \n 9 January 2018\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n NDCLS\n \n \n \n \n OCH\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Radcliffe Department of Medicine has launched a new initiative \u2013 the Oxford Centre for Haematology (OCH). Through this virtual Centre we aim to promote integration between academic and clinical haematology programmes in the University and Oxford University Hospital NHS Foundation Trust and thereby capitalise on scientific opportunities to transform our understanding of haemopoiesis and blood diseases.
\n \n\n\n \n 5 January 2018\n \n
\n\n \n\n \n\n \n \n \n \n NDCLS\n \n \n \n \n OCH\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nCongratulations to Prof Jackie Boultwood and Dr Andrea Pellagatti, who have been awarded a project grant from Leuka \u2013 a leading leukaemia research charity. Their work will focus on Chronic myelomonocytic leukaemia (CMML), a blood cancer with a poor prognosis and limited treatment options.
\n \n\n\n \n 29 September 2017\n \n
\n\n \n\n \n\n \n \n \n \n MRC MHU\n \n \n \n \n MRC WIMM\n \n \n \n \n OCH\n \n \n\n \n\n\n
\n \n\n \n \n \nMembers of the Oxford and Thames Valley MDS Patient Support Group, which provides support to those affected by Myelodysplastic Syndromes, visited the MRC Weatherall Institute of Molecular Medicine (WIMM) on Friday 29 September. The visit was hosted by Dr Lynn Quek and members of Prof Paresh Vyas' research team at the MRC Molecular Hematology Unit, who are members of the Radcliffe Department of Medicine. Their research is supported by the NIHR Oxford Biomedical Research Centre.
\n \n\n\n \n 21 September 2017\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n NDCLS\n \n \n \n \n OCH\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nNew research shows that blood donors could safely give blood more frequently than is allowed at present. At the moment in the UK men can give blood every 12 weeks, women every 16 weeks. The new research demonstrates that in certain situations and for certain donors, shortening the donation interval is a viable approach for blood services to take.
\n \n\n